The outcomes and risk factors of fetal bradycardia associated with external cephalic version.


Journal

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
ISSN: 1476-4954
Titre abrégé: J Matern Fetal Neonatal Med
Pays: England
ID NLM: 101136916

Informations de publication

Date de publication:
Mar 2019
Historique:
pubmed: 24 10 2017
medline: 4 4 2019
entrez: 24 10 2017
Statut: ppublish

Résumé

The objective of this study is to assess the outcomes and risk factors of fetal bradycardia after external cephalic version (ECV). We performed a retrospective study of women who underwent ECV after 35 weeks of gestation in 2010-2016. We assessed the birth outcomes, including umbilical cord artery pH, according to the duration of fetal bradycardia and the risk factors for bradycardia. Among 390 cases, 189 (48.5%) cases showed fetal bradycardia during or immediately after ECV. The duration of fetal bradycardia was <1 min (n = 82, 43.4%), <5 min (n = 168, 88.9%); and <10 min (n = 186, 98.4%). All cases showed a good prognosis. Fetal bradycardia lasting >10 min occurred in three cases; emergency cesarean section was performed in each case, with delivery after 12-4 min of bradycardia. Two of three cases showed low Apgar scores at 5 min, with an umbilical cord arterial pH of <7.1. Lower maternal BMI and a prolonged ECV procedure were significantly associated with bradycardia (p for trend: .016 and .015, respectively). Fetal bradycardia lasting >10 min after ECV was a risk factor for asphyxia. Thus, delivery should be completed within 10 min after bradycardia. A low maternal BMI and a prolonged ECV procedure were risk factors for bradycardia after ECV.

Identifiants

pubmed: 29057691
doi: 10.1080/14767058.2017.1395846
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

922-926

Auteurs

Fumio Suyama (F)

a Center of Maternal-Fetal, Neonatal and Reproductive Medicine , National Center for Child Health and Development , Tokyo , Japan.

Kohei Ogawa (K)

a Center of Maternal-Fetal, Neonatal and Reproductive Medicine , National Center for Child Health and Development , Tokyo , Japan.

Yukiko Tazaki (Y)

b Department of Obstetrics , Fukuoka Children's Hospital , Fukuoka , Japan.

Terumi Miwa (T)

a Center of Maternal-Fetal, Neonatal and Reproductive Medicine , National Center for Child Health and Development , Tokyo , Japan.

Kosuke Taniguchi (K)

a Center of Maternal-Fetal, Neonatal and Reproductive Medicine , National Center for Child Health and Development , Tokyo , Japan.

Noriyuki Nakamura (N)

a Center of Maternal-Fetal, Neonatal and Reproductive Medicine , National Center for Child Health and Development , Tokyo , Japan.

Satomi Tanaka (S)

a Center of Maternal-Fetal, Neonatal and Reproductive Medicine , National Center for Child Health and Development , Tokyo , Japan.

Shinji Tanigaki (S)

a Center of Maternal-Fetal, Neonatal and Reproductive Medicine , National Center for Child Health and Development , Tokyo , Japan.

Haruhiko Sago (H)

a Center of Maternal-Fetal, Neonatal and Reproductive Medicine , National Center for Child Health and Development , Tokyo , Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH